Humayun Islam, MD
Anatomic Pathology & Clinical Pathology · Valhalla, NYNPI 1902976947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Sanofi US Services Inc. at 26.1% of the total.
Across 7 payments — averaging $42.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$78
- Bristol Myers Squibb$74
- Seagen Inc.$65
- Roche Diagnostics Corporation$35
- Merck$24
- Janssen Scientific Affairs, LLC$23
Across 9 payments — averaging $34,394 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$310K
What the payments were for
- Food & beverage$299100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 1 | $78 |
| Bristol Myers Squibb | 1 | $74 |
| Seagen Inc. | 1 | $65 |
| Roche Diagnostics Corporation | 2 | $35 |
| Merck | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
How this compares
$299 in reported general payments places this provider in the 75th percentile of 468 anatomic pathology & clinical pathology providers in New York.
See all anatomic pathology & clinical pathology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Valhalla
- Jeffrey RossAlbany$110K
- Adebowale AdeniranNew York$106K
- Erin MarnerRochester$97K
- Leal HerlitzNew York$92K
- Shabnam JafferNew York$69K
- Judy SarungbamBronx$67K
- Zhi-Qiang Patrick HuFlushing$65K
- Hannah WenNew York$60K
- Soo Ryum YangNew York$60K
- Mary BeasleyNew York$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.